Zobrazeno 1 - 10
of 2 578
pro vyhledávání: '"Loge, C."'
Autor:
Hobbie, Erik A.1 (AUTHOR) Erik.Hobbie@unh.edu, Siegwolf, Rolf2,3 (AUTHOR), Körner, Christian4 (AUTHOR), Steinmann, Katharina2 (AUTHOR), Wilhelm, Markus5 (AUTHOR), Saurer, Matthias2,3 (AUTHOR), Keel, Sonja G.4,6 (AUTHOR)
Publikováno v:
Plant & Soil. Jan2024, Vol. 494 Issue 1/2, p717-730. 14p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Patient Related Outcome Measures, Vol Volume 12, Pp 247-265 (2021)
Christine de la Loge,1 Fatoumata Fofana,2 Paul Williams,1 Sarah Rusch,3 Marita Stevens,4 Jane Scott5 1Patient-Centered Outcomes, Mapi (an ICON Plc. company), Lyon, France; 2Patient-Centered Outcomes, Mapi (an ICON Plc. company), Leiden, the Netherlan
Externí odkaz:
https://doaj.org/article/eae5688fa11e40caad6938a0313badca
Autor:
Bourikas D; UCB, Agiou Dimitriou 63, Alimos 17456, Greece. Electronic address: dimitrios.bourikas@ucb.com., Koch J; UCB, Rolf-Schwarz-Schütte-Platz 1, Monheim am Rhein 40789, Germany. Electronic address: juliane.koch@ucb.com., de la Loge C; UCB, Allée de la Recherche 60, Brussels 1070, Belgium. Electronic address: christine.delaloge@ucb.com., Dimova S; UCB, Allée de la Recherche 60, Brussels 1070, Belgium. Electronic address: svetlana.dimova@ucb.com., Elmoufti S; UCB, 4000 Paramount Parkway, Morrisville, NC 27560, USA. Electronic address: sami.elmoufti@ucb.com., Moseley B; UCB, 4000 Paramount Parkway, Morrisville, NC 27560, USA. Electronic address: brian.moseley@ucb.com., Lagae L; Pediatric Neurology, University Hospitals KU Leuven, Herestraat 49, Leuven 3000, Belgium. Electronic address: lieven.lagae@uzleuven.be.
Publikováno v:
Epilepsy research [Epilepsy Res] 2024 Dec 04; Vol. 209, pp. 107482. Date of Electronic Publication: 2024 Dec 04.
Autor:
Navarro-Compán V; V. Navarro-Compán, MD, PhD, MSc, Department of Rheumatology, La Paz University Hospital, IdiPaz, Madrid, Spain., Rudwaleit M; M. Rudwaleit, MD, University of Bielefeld, Klinikum Bielefeld, Bielefeld, Germany., Dubreuil M; M. Dubreuil, MD, MSc, Section of Rheumatology, Boston University School of Medicine, Boston, Massachusetts, USA., Magrey M; M. Magrey, MD, Case Western Reserve University, University Hospitals, Cleveland, Ohio, USA., Marzo-Ortega H; H. Marzo-Ortega, LMS, PhD, NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK., Mease PJ; P.J. Mease, MD, Swedish Medical Center and Providence St. Joseph Health and University of Washington, Seattle, Washington, USA., Walsh JA; J.A. Walsh, MD, Division of Rheumatology, Salt Lake City Veterans Affairs Health and University of Utah Health, Salt Lake City, Utah, USA., Dougados M; M. Dougados, MD, PhD, Department of Rheumatology, Hôpital Cochin, University of Paris Cité, Paris, France., de la Loge C; C. de la Loge, MSc, Brussels, Belgium., Fleurinck C; C. Fleurinck, MD, UCB, Brussels, Belgium., Massow U; U. Massow, PhD, UCB, Monheim am Rhein, Germany., Vaux T; T. Vaux, MSc, UCB, Slough, UK., Taieb V; V. Taieb, MSc, UCB, Colombes, France., Deodhar A; A. Deodhar, MD, MRCP, Division of Arthritis and Rheumatic Diseases, Oregon Health & Science University, Portland, Oregon, USA.
Publikováno v:
The Journal of rheumatology [J Rheumatol] 2024 Oct 15. Date of Electronic Publication: 2024 Oct 15.
Autor:
Farkas MK; Pediatric Center, Semmelweis University, Bókay János u. 53-54, Budapest 1083, Hungary. Electronic address: kristofm.farkas@gmail.com., Makedonska I; Dnipro City Pediatric Clinical Hospital, 5 Ivana Akinfieva St, Dnipro 49027, Ukraine. Electronic address: iryna.maked@gmail.com., Beller C; UCB Pharma, Morrisville, NC, United States. Electronic address: Cynthia.Beller@ucb.com., Bourikas D; UCB Pharma, Agiou Dimitriou 63, Alimos 17456, Greece. Electronic address: Dimitrios.Bourikas@ucb.com., de la Loge C; UCB Pharma, Allée de la Recherche 60, 1070 Brussels, Belgium. Electronic address: Christine.Delaloge@ucb.com., Dimova S; UCB Pharma, Allée de la Recherche 60, 1070 Brussels, Belgium. Electronic address: Svetlana.Dimova@ucb.com., Floricel F; UCB Pharma, Alfred-Nobel-Straße 10, 40789 Monheim am Rhein, Germany. Electronic address: Florin.Floricel@ucb.com., McClung C; UCB Pharma, Morrisville, NC, United States. Electronic address: Carrie.McClung@ucb.com., Moseley B; UCB Pharma, Morrisville, NC, United States. Electronic address: Brian.Moseley@ucb.com., Therriault S; UCB Pharma, Morrisville, NC, United States. Electronic address: sheila.therriault@gmail.com., Pina-Garza JE; TriStar Medical Group Children's Specialists, 330 23rd Ave North Ste 450, Nashville, TN 37203, United States. Electronic address: Jesus.PinaGarza@hcahealthcare.com.
Publikováno v:
Epilepsy & behavior : E&B [Epilepsy Behav] 2024 Oct; Vol. 159, pp. 109989. Date of Electronic Publication: 2024 Aug 30.
Autor:
Cella D; Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Evanston, IL, USA. axSpAFacit-Fatigue@costellomedical.com., de la Loge C; PCOM Analytics, Avallon, France., Fofana F; Evidera, Zonneoordlaan, Netherlands., Guo S; Evidera, Waltham, MA, USA., Ellis A; UCB Pharma, Raleigh, NC, USA., Fleurinck C; UCB Pharma, Brussels, Belgium., Massow U; UCB Pharma, Monheim, Germany., Dougados M; Department of Rheumatology, Hôpital Cochin, University Paris Cité, Paris, France., Navarro-Compán V; Department of Rheumatology, La Paz University Hospital, IdiPaz, Madrid, Spain., Walsh JA; Salt Lake City Veterans Affairs Health and University of Utah Health, Salt Lake City, UT, USA.
Publikováno v:
Journal of patient-reported outcomes [J Patient Rep Outcomes] 2024 Aug 12; Vol. 8 (1), pp. 92. Date of Electronic Publication: 2024 Aug 12.
Autor:
Dubreuil M; Department of Rheumatology, Boston University School of Medicine, Boston, Massachusetts, USA mdubreui@bu.edu., Navarro-Compán V; Department of Rheumatology, La Paz University Hospital, IdiPaz, Madrid, Spain., Boonen A; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, The Netherlands.; Care and Public Health Research Institute (Caphri), Maastricht University, Maastricht, The Netherlands., Gaffney K; Norfolk and Norwich University Hospital NHS Trust, Norfolk, UK., Gensler LS; Department of Medicine/Rheumatology, University of California San Francisco, San Francisco, California, USA., de la Loge C; UCB Pharma, Brussels, Belgium., Vaux T; UCB Pharma, Slough, UK., Fleurinck C; UCB Pharma, Brussels, Belgium., Massow U; UCB Pharma, Monheim am Rhein, Germany., Taieb V; UCB Pharma, Colombes, France., Mørup MF; UCB Pharma, Copenhagen, Denmark., Deodhar A; Division of Arthritis & Rheumatic Diseases, Oregon Health & Science University, Portland, Oregon, USA., Rudwaleit M; University of Bielefeld, Klinikum Bielefeld, Bielefeld, Germany.
Publikováno v:
RMD open [RMD Open] 2024 Jun 04; Vol. 10 (2). Date of Electronic Publication: 2024 Jun 04.
Autor:
Navarro-Compán V; Department of Rheumatology, La Paz University Hospital, Madrid, Spain mvictoria.navarroc@gmail.com., Ramiro S; Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands.; Department of Rheumatology, Zuyderland Medical Centre Heerlen, Heerlen, Netherlands., Deodhar A; Division of Arthritis & Rheumatic Diseases, Oregon Health & Science University, Portland, Oregon, USA., Mease PJ; School of Medicine, Swedish Medical Center and University, Seattle, Washington, USA., Rudwaleit M; Internal Medicine and Rheumatology, Klinikum Bielefeld Rosenhöhe, Bielefeld, Germany., de la Loge C; PCOM Analytics, Avallon, France., Fleurinck C; UCB Pharma, Brussels, Belgium., Taieb V; UCB Pharma, Colombes, France., Mørup MF; UCB Pharma, Copenhagen, Denmark., Massow U; UCB Pharma, Monheim am Rhein, Germany., Kay J; Division of Rheumatology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA., Magrey M; Case Western Reserve University, Cleveland, Ohio, USA.
Publikováno v:
RMD open [RMD Open] 2024 Apr 10; Vol. 10 (2). Date of Electronic Publication: 2024 Apr 10.
Autor:
Baraliakos, X., Deodhar, A., Dougados, M., Gensler, L.S., Molto, A., Ramiro, S., Kivitz, A.J., Poddubnyy, D., Oortgiesen, M., Vaux, T., Fleurinck, C., Shepherd-Smith, J., Loge, C. de la, Peyrecave, N. de, Heijde, D. van der
Publikováno v:
Arthritis and Rheumatology. WILEY
Arthritis and Rheumatology
Arthritis and Rheumatology
Objective To assess the long-term safety, tolerability, and efficacy of bimekizumab in patients with active ankylosing spondylitis (AS). Methods Patients with active AS who completed the dose-ranging, 48-week BE AGILE randomized controlled trial were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5b2389ff3609fef6fee1161cf9335bdc
http://hdl.handle.net/1887/3503929
http://hdl.handle.net/1887/3503929